According to the research report of Central China Securities, the valuation of the planting industry is at a historically relatively low level. After the release of previous negative sentiment, the current planting sector has significant investment value in the face of the potential market space for biological breeding. 2024 is the first year of China's biological breeding. The seed enterprises that have passed the initial variety review have already obtained production and operation licenses, and related listed companies are expected to benefit from the dual increase in industry concentration and profit margin.